Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China
· Delayed Price · Currency is CNY 29.99
-0.24 (-0.79%)
Feb 28, 2025, 3:00 PM CST
SHA:600329 Revenue
Tianjin Pharmaceutical Da Ren Tang Group Corporation had revenue of 1.65B CNY in the quarter ending September 30, 2024, a decrease of -3.43%. This brings the company's revenue in the last twelve months to 8.04B, down -5.18% year-over-year. In the year 2023, Tianjin Pharmaceutical Da Ren Tang Group Corporation had annual revenue of 8.22B, down -0.33%.
Revenue (ttm)
8.04B
Revenue Growth
-5.18%
P/S Ratio
2.87
Revenue / Employee
1.74M
Employees
4,619
Market Cap
20.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 8.22B | -26.94M | -0.33% |
| Dec 31, 2022 | 8.25B | 1.34B | 19.42% |
| Dec 31, 2021 | 6.91B | 303.89M | 4.60% |
| Dec 31, 2020 | 6.60B | -390.23M | -5.58% |
| Dec 31, 2019 | 6.99B | 635.26M | 9.99% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Sichuan Biokin Pharmaceutical | 5.85B |